Hermann Wätzig

Prof. Hermann Wätzig


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Electrophoresis
Verified
Journal Article
Open access
PDF file
CSChristin Scheller
Christin Scheller
FKFinja Krebs
Finja Krebs
RMRobert Minkner
Robert Minkner
IAIsabel Astner
Isabel Astner
MGMaria Gil‐Moles
Maria Gil‐Moles
HWHermann Wätzig
Hermann Wätzig
The material properties of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and its proteins are discussed. We review the viral structure, size, rigidity, lipophilicity, isoelectric point, buoyant density and centrifugation conditions, stability against pH, temperature, UV light, gamma radiation, and susceptibility to various chemical agents including solvents and detergents. Possible inactivation, downstream, and formulation conditions are given including suitable buffers and some first ideas for quality‐control methods. This information supports vaccine development and discussion with competent authorities during vaccine approval and is certainly related to drug‐targeting strategies and hygienics. Several instructive tables are given, including the pI and grand average of hydropathicity (GRAVY) of SARS‐CoV‐1 and ‐2 proteins in comparison. SARS‐CoV‐1 and SARS‐CoV‐2 are similar in many regards, so information can often be derived. Both are unusually stable, but sensitive at their lipophilic membranes. However, since seemingly small differences can have strong effects, for example, on immunologically relevant epitope settings, unevaluated knowledge transfer from SARS‐CoV‐1 to SARS‐CoV‐2 cannot be advised. Published knowledge regarding downstream processes, formulations and quality assuring methods is, as yet, limited. However, standard approaches employed for other viruses and vaccines seem to be feasible including virus inactivation, centrifugation conditions, and the use of adjuvants.

20 June 2005 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
MGMichael Graf
Michael Graf
RGRaquel Galera García
Raquel Galera García
HWHermann Wätzig
Hermann Wätzig

1 August 2018 in Methods
Verified
Journal Article
Closed access
MOMais Olabi
Mais Olabi
MSMatthias Oliver Stein
Matthias Oliver Stein
HWHermann Wätzig
Hermann Wätzig

3 August 2023 in Electrophoresis
Verified
Journal Article
Open access
FKFinja Krebs
Finja Krebs
HZHolger Zagst
Holger Zagst
MSMatthias Stein
Matthias Stein
RRRatih Ratih
Ratih Ratih
RMRobert Minkner
Robert Minkner
HWHermann Wätzig
Hermann Wätzig
This review is in support of the development of selective, precise, fast, and validated capillary electrophoresis (CE) methods. It follows up a similar article from 1998, Wätzig H, Degenhardt M, Kunkel A. “Strategies for capillary electrophoresis: method development and validation for pharmaceutical and biological applications,” pointing out which fundamentals are still valid and at the same time showing the enormous achievements in the last 25 years. The structures of both reviews are widely similar, in order to facilitate their simultaneous use. Focusing on pharmaceutical and biological applications, the successful use of CE is now demonstrated by more than 600 carefully selected references. Many of those are recent reviews; therefore, a significant overview about the field is provided. There are extra sections about sample pretreatment related to CE and microchip CE, and a completely revised section about method development for protein analytes and biomolecules in general. The general strategies for method development are summed up with regard to selectivity, efficiency, precision, analysis time, limit of detection, sample pretreatment requirements, and validation.

13 November 2020 in Electrophoresis
Verified
Journal Article
Open access
PDF file
RWRebecca Wiesner
Rebecca Wiesner
CSChristin Scheller
Christin Scheller
FKFinja Krebs
Finja Krebs
HWHermann Wätzig
Hermann Wätzig
IOImke Oltmann‐Norden
Imke Oltmann‐Norden
The development of capillary electrophoresis, especially CE‐SDS devices, has led CE‐SDS to become an established tool in a wide range of applications in the analysis of biopharmaceuticals and is increasingly replacing its method of origin, SDS‐PAGE. The goal of this study was to evaluate the comparability of molecular weight (MW) determination especially by CE‐SDS and SDS‐PAGE. For ensuring comparability, model proteins that have little or no posttranslational modifications and an IgG antibody were used. Only a minor influence of sample preparation conditions, including sample buffer, temperature conditions, and different reducing agents on the MW determination were found. In contrast, the selection of the MW marker plays a decisive role in determining the accurate apparent MW of a protein. When using different MW markers, the deviation in MW determination can exceed 10%. Interestingly, CE‐SDS and 10% SDS‐PAGE hardly differ in their trueness of MW determination. The trueness in relation to the reference MW for each protein was calculated. Although the trueness values for the model proteins considered range between 1.00 and 1.11 using CE‐SDS, they range between 0.93 and 1.03 on SDS‐PAGE, depending on the experimental conditions chosen.

28 December 2009 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
DEDeia El-Hady
Deia El-Hady
SKSascha Kühne
Sascha Kühne
NENagwa El-Maali
Nagwa El-Maali
HWHermann Wätzig
Hermann Wätzig